Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. | Comput Biol Med | 2022 | 36201886 | PubTator, text mining | PubMed |
| Muscle fibro-adipogenic progenitors from a single-cell perspective: Focus on their "virtual" secretome. | Front Cell Dev Biol | 2022 | 36200044 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Angioedema with Three Possible Etiologies. | Kans J Med | 2022 | 36196108 | PubTator, text mining | PubMed |
| Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer. | Front Immunol | 2022 | 36189269 | PubTator, text mining | PubMed |
| The role of the complement system in kidney glomerular capillary thrombosis. | Front Immunol | 2022 | 36189215 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor. | Front Med (Lausanne) | 2022 | 36186797 | PubTator, text mining | PubMed |
| Opti-4TB: A protocol for a prospective cohort study evaluating the performance of new biomarkers for active tuberculosis outcome prediction. | Front Med (Lausanne) | 2022 | 36186786 | PubTator, text mining | PubMed |
| Frozen and freeze-dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality. | Transfusion | 2022 | 36181447 | PubTator, text mining | PubMed |
| Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain. | Cell | 2022 | 36179668 | PubTator, text mining | PubMed |
| Treatment of hereditary angioedema-single or multiple pathways to the rescue. | Front Allergy | 2022 | 36172291 | PubTator, text mining | PubMed |
| The viral and inflammation hypothesis of epileptic seizures based on bioinformatic study of circulating miRNAs and peripheral whole-blood mRNAs of adult epilepsy patients. | Front Neurol | 2022 | 36172025 | PubTator, text mining | PubMed |
| Perioperative management of emergency caesarean section in type I hereditary angioedema. | J Anaesthesiol Clin Pharmacol | 2022 | 36171940 | PubTator, text mining | PubMed |
| A challenging diagnosis: hereditary angioedema presenting during pregnancy. | CMAJ | 2022 | 36162836 | PubTator, text mining | PubMed |
| Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities. | Front Cardiovasc Med | 2022 | 36158829 | PubTator, text mining | PubMed |
| Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review. | World J Exp Med | 2022 | 36157337 | PubTator, text mining | PubMed |
| In vitro reconstitution of kallikrein-kinin system and progress curve analysis. | Biosci Rep | 2022 | 36156118 | PubTator, text mining | PubMed |
| Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies. | Allergy Asthma Clin Immunol | 2022 | 36153561 | PubTator, text mining | PubMed |
| The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency. | Int J Mol Sci | 2022 | 36142237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=43